Back to Browse Journals

ImmunoTargets and Therapy


Dr Shurin

Departments of Pathology and Immunology, University of Pittsburgh Medical Center, United States

Dr Shurin

Editor-in-Chief: Michael R Shurin

Michael R. Shurin, MD, PhD is a Professor of Pathology and Immunology at the University of Pittsburgh Medical Center and an associate director of the Division of Clinical Immunopathology. After graduation from medical school in Moscow and additional clinical training, Professor Shurin proceeded his research career in psychoneuroimmunology and obtained a PhD degree in immunopharmacology from the State Research Institute for Pharmacology in Moscow, Russia. From 1991, Michael Shurin was a member of the faculty at the University of Pittsburgh at the departments of surgery and pathology. He leads a unique research program focusing on cellular and molecular interactions in the tumor microenvironment supported by NIH and other foundations.

He is well known for his studies on dendritic cells in cancer. Professor Shurin has published more than 200 papers, reviews and book chapters, edited four books, including “The Tumor Immunoenvironment” and “Infection and Cancer: Bidirectorial Interactions”, organized several international conferences on immune-mediated diseases, immunodiagnostics and cancer immunotherapy. He served on NIH, DoD and ACS study session, several editorial boards and advisory committees.


Editorial Board

Robert J. Amato, Professor of Oncology, Department of Internal Medicine, The University of Texas Health Science Centre at Houston, Houston, TX, USA

Natalia Aptsiauri, Department of Clinical Analysis and Immunology, University of Granada Medical School Hospitals and Clinics, Spain

Gurkamal Chatta, Roswell Park Cancer Institute, Buffalo, NY, USA

Ramon Kaneno, Associate Professor and Head of the Department of Microbiology and Immunology, Institute of Biosciences of Botucatu - UNESP - Sao Paulo State University, Botucatu, SP, Brazil

Ken-ichiro Kosai, Professor and Chairman, Department of Gene Therapy and Regenerative Medicine; Director, Center for Innovative Therapy Research and Application, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

Maciej Lesniak, Michael J. Marchese Professor and Chair, Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Yangqiu Li, Professor of Medicine and the Director of Institute of Hematology of Medical College, Jinan University, People's Republic of China

Azzam A. Maghazachi, Professor, College of Medicine, University of Sharjah, Sharjah, United Arabs Emirates

Kamal Moudgil, Professor, Department of Microbiology and Immunology, Division of Rheumatology, Department of Medicine, University of Maryland, School of Medicine, Baltimore, MD, USA

Kiat Ruxrungtham, Professor of Medicine, ChulaVRC (Vaccine Research Center), Division of Allergy and Clinical Immunology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

Franco Maria Venanzi, Professor in Physiology, School of Biosciences and Veterinary Medicine, University of Camerino (UNICAM), Camerino, Italy.

Richard Warrington, Professor of Medicine & Immunology at the University of Manitoba, Winnipeg, Canada

Theresa L. Whiteside, PhD, MDHC, Professor of Pathology, Immunology and Otolaryngology, University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA

Qizhi (Cathy) Yao, Professor, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA